women with advanced cervical cancer – the most common cancer afflicting young women – are to get the first officially approved new treatment for a decade . trials show avastin , which is used in several other cancers , gives women around four months’ extra life . nearly 3,000 women are diagnosed with cervical cancer in the uk each year , and it kills around 1,000 women . avastin is an antibody that precisely targets and inhibits vegf .